Slow Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.51M Sell
12,409
-7,071
-36% -$3.71M 0.8% 34
2025
Q1
$12.4M Buy
19,480
+6,715
+53% +$4.26M 1.65% 17
2024
Q4
$9.09M Buy
12,765
+410
+3% +$292K 1.29% 17
2024
Q3
$13M Buy
12,355
+241
+2% +$253K 1.99% 14
2024
Q2
$12.7M Buy
12,114
+74
+0.6% +$77.8K 2.06% 14
2024
Q1
$11.6M Buy
12,040
+196
+2% +$189K 1.86% 14
2023
Q4
$10.4M Buy
11,844
+47
+0.4% +$41.3K 1.81% 14
2023
Q3
$9.71M Buy
11,797
+208
+2% +$171K 1.78% 14
2023
Q2
$8.33M Sell
11,589
-167
-1% -$120K 1.45% 15
2023
Q1
$9.66M Buy
11,756
+150
+1% +$123K 1.81% 12
2022
Q4
$8.37M Buy
11,606
+307
+3% +$221K 1.86% 12
2022
Q3
$7.78M Buy
11,299
+1,118
+11% +$770K 1.68% 13
2022
Q2
$6.02M Buy
10,181
+3,040
+43% +$1.8M 1.46% 13
2022
Q1
$4.99M Buy
7,141
+3,179
+80% +$2.22M 0.93% 20
2021
Q4
$2.5M Buy
3,962
+533
+16% +$337K 0.43% 84
2021
Q3
$2.08M Sell
3,429
-346
-9% -$209K 0.38% 92
2021
Q2
$2.11M Buy
3,775
+251
+7% +$140K 0.4% 91
2021
Q1
$1.9M Buy
3,524
+897
+34% +$482K 0.41% 91
2020
Q4
$1.27M Buy
2,627
+242
+10% +$117K 0.3% 115
2020
Q3
$1.34M Buy
2,385
+80
+3% +$44.8K 0.36% 104
2020
Q2
$1.44M Sell
2,305
-67
-3% -$41.8K 0.42% 91
2020
Q1
$1.16M Buy
2,372
+288
+14% +$141K 0.44% 91
2019
Q4
$782K Buy
2,084
+1,153
+124% +$433K 0.24% 125
2019
Q3
$258K Buy
+931
New +$258K 0.09% 155
2019
Q2
Sell
-2,213
Closed -$909K 172
2019
Q1
$909K Buy
2,213
+42
+2% +$17.3K 0.36% 93
2018
Q4
$811K Buy
2,171
+304
+16% +$114K 0.39% 86
2018
Q3
$754K Buy
1,867
+60
+3% +$24.2K 0.34% 96
2018
Q2
$623K Sell
1,807
-308
-15% -$106K 0.32% 99
2018
Q1
$728K Buy
2,115
+638
+43% +$220K 0.33% 100
2017
Q4
$555K Buy
+1,477
New +$555K 0.29% 102